These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8527274)

  • 21. The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media.
    Siau H; Kerridge D
    J Antimicrob Chemother; 1998 Mar; 41(3):357-66. PubMed ID: 9578162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR; Torres-Rodríguez JM
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.
    Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO
    Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells.
    Pawelec G; Ehninger G; Rehbein A; Schaudt K; Jaschonek K
    Int J Immunopharmacol; 1991; 13(2-3):299-304. PubMed ID: 1649144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of inhibition potentials of drugs against zidovudine glucuronidation in rat hepatocytes and liver microsomes.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Apr; 35(4):602-6. PubMed ID: 17267620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
    Yangco BG; Okafor JI; TeStrake D
    Antimicrob Agents Chemother; 1984 Apr; 25(4):413-6. PubMed ID: 6329078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    Turnidge JD; Gudmundsson S; Vogelman B; Craig WA
    J Antimicrob Chemother; 1994 Jul; 34(1):83-92. PubMed ID: 7961219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole.
    Wang JS; Wen X; Backman JT; Taavitsainen P; Neuvonen PJ; Kivistö KT
    Pharmacol Toxicol; 1999 Oct; 85(4):157-61. PubMed ID: 10563513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
    Goudard M; Regli P; Buffard Y; Gabriel B
    Pathol Biol (Paris); 1988 Feb; 36(2):139-43. PubMed ID: 3279381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "In vitro" evaluation of Aspergillus susceptibility to antifungal agents.
    Viviani MA; Tortorano AM
    Ann Sclavo; 1982; 24(6):642-50. PubMed ID: 6320751
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.
    Quindós G; Carrillo-Muñoz AJ; Arévalo MP; Salgado J; Alonso-Vargas R; Rodrigo JM; Ruesga MT; Valverde A; Pemán J; Cantón E; Martín-Mazuelos E; Pontón J
    Chemotherapy; 2000; 46(6):395-401. PubMed ID: 11053905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
    Walsh TJ; Peter J; McGough DA; Fothergill AW; Rinaldi MG; Pizzo PA
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1361-4. PubMed ID: 7574531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conazoles.
    Heeres J; Meerpoel L; Lewi P
    Molecules; 2010 Jun; 15(6):4129-88. PubMed ID: 20657432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM; Mader JT; Davis CP
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.